Zealand Pharma A/S (ZEAL.CO)

DKK 802.5

(0.44%)

Gross Profit Summary of Zealand Pharma A/S

  • Zealand Pharma A/S's latest annual gross profit in 2023 was 323.61 Million DKK , up 303.02% from previous year.
  • Zealand Pharma A/S's latest quarterly gross profit in 2024 Q2 was 17.87 Million DKK , up 536.09% from previous quarter.
  • Zealand Pharma A/S reported a annual gross profit of 73.27 Million DKK in annual gross profit 2022, down -57.83% from previous year.
  • Zealand Pharma A/S reported a annual gross profit of 173.75 Million DKK in annual gross profit 2021, down -33.87% from previous year.
  • Zealand Pharma A/S reported a quarterly gross profit of 3.87 Million DKK for 2024 Q1, down -58.0% from previous quarter.
  • Zealand Pharma A/S reported a quarterly gross profit of 9.22 Million DKK for 2023 Q4, down -96.82% from previous quarter.

Annual Gross Profit Chart of Zealand Pharma A/S (2023 - 2007)

Historical Annual Gross Profit of Zealand Pharma A/S (2023 - 2007)

Year Gross Profit Gross Profit Growth
2023 323.61 Million DKK 303.02%
2022 73.27 Million DKK -57.83%
2021 173.75 Million DKK -33.87%
2020 262.74 Million DKK 542.14%
2019 40.91 Million DKK 128.76%
2018 -142.26 Million DKK -213.68%
2017 125.14 Million DKK -38.45%
2016 203.31 Million DKK 22.92%
2015 165.41 Million DKK 18.15%
2014 139.99 Million DKK 2355.23%
2013 5.7 Million DKK -97.25%
2012 207.63 Million DKK 46.04%
2011 142.17 Million DKK 62.75%
2010 87.35 Million DKK 245.03%
2009 25.31 Million DKK -55.0%
2008 56.26 Million DKK -6.11%
2007 59.92 Million DKK 0.0%

Peer Gross Profit Comparison of Zealand Pharma A/S

Name Gross Profit Gross Profit Difference
ALK-Abelló A/S 3.03 Billion DKK 89.337%
Bavarian Nordic A/S 4.52 Billion DKK 92.843%
Genmab A/S 16.24 Billion DKK 98.008%
Gubra A/S 114.93 Million DKK -181.56%
Novo Nordisk A/S 196.49 Billion DKK 99.835%
Orphazyme A/S - DKK -Infinity%
Pharma Equity Group A/S -480 Thousand DKK 67519.583%